English
Home > Products > 49745-95-1

China 49745-95-1 Factory

Our solutions are broadly acknowledged and dependable by users and may meet consistently developing economic and social requires for 49745-95-1,CAS NO 49745-95-1,Desloratadine API, We welcome clients, business enterprise associations and mates from all pieces from the earth to make contact with us and request cooperation for mutual advantages.
49745-95-1, Our company has a skillful sales team, strong economic foundation, great technical force, advanced equipment, complete testing means, and excellent after-sales services. Our items have beautiful appearance, fine workmanship and superior quality and win the unanimous approvals of the customers all over the world.

Related Products

Hot Products

  • 2-Chloro-1-(3,4-difluoro-phenyl)-ethanone

    2-Chloro-1-(3,4-difluoro-phenyl)-ethanone

    Product Name:2-Chloro-1-(3,4-difluoro-phenyl)-ethanone
    Molecular Formula:C8H5ClF2O
    Molecular Weight:190.57
    CAS Registry Number:51336-95-9
  • 1-(Perfluorobut-1-yl)pentane

    1-(Perfluorobut-1-yl)pentane

    Product Name:1-(Perfluorobut-1-yl)pentane
    Molecular Formula:C9H11F9
    Molecular Weight:290.17
    CAS Registry Number:1190430-21-7
  • 2-Amino-5-methylpyridine

    2-Amino-5-methylpyridine

    Product Name:2-Amino-5-methylpyridine
    Molecular Formula:C6H8N2
    Molecular Weight:108.14
    CAS Registry Number:1603-41-4
  • Clarithromycin lactobionate

    Clarithromycin lactobionate

    Product Name:Clarithromycin lactobionate
    Molecular Formula:C50H89NO24
    Molecular Weight;1088.24
    CAS Registry Number;135326-55-5
  • Triphosphopyridine nucleotide

    Triphosphopyridine nucleotide

    Product Name:Triphosphopyridine nucleotide
    Molecular Formula:C21H28N7O17P3
    Molecular Weight;743.41
    CAS Registry Number;53-59-8
  • Gadopentetate Dimeglumine

    Gadopentetate Dimeglumine

    Product Name:Gadopentetate Dimeglumine
    Molecular Weight:938.00
    CAS Registry Number:86050-77-3
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 49745-95-1

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept